FDA approves first twice-yearly injection that prevents HIV infection
|
The FDA has approved Yetzugo, Gilead Sciences'
twice-yearly injectable HIV prevention treatment, which showed nearly
100% effectiveness in ... |
Nigeria : New HIV Drug May Exclude Vulnerable Populations
The recent approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, has sparked global debate as health experts warn that its ... View article...